2f:I[703058,["/_next/static/immutable/chunks/3bhq_5eh1d760.js","/_next/static/immutable/chunks/1855-ogyi8eh4.js","/_next/static/immutable/chunks/2pfsjpn6k6zlg.js","/_next/static/immutable/chunks/26c7v3_3uwnwu.js","/_next/static/immutable/chunks/25a3ozcrvi1ff.js","/_next/static/immutable/chunks/2r4wx50nvjh_4.js","/_next/static/immutable/chunks/23fsw06hsi5b1.js","/_next/static/immutable/chunks/06_yt270h41rg.js","/_next/static/immutable/chunks/3ezsiz-7shkna.js","/_next/static/immutable/chunks/20x2y96ldu5wx.js","/_next/static/immutable/chunks/2lxntcm3pd1_h.js","/_next/static/immutable/chunks/00dgco8irq3jw.js","/_next/static/immutable/chunks/00nwe-kq0rboc.js","/_next/static/immutable/chunks/2051ffx3xzio9.js"],"PaperListPageClient"] 30:Taed,Solid organ transplant (SOT) recipients are at increased risk for skin cancer due to long-term immunosuppression. However, this risk is heterogeneous across the SOT population. The Skin and Ultraviolet Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) incorporates established clinical risk factors to stratify SOT recipients into low-, medium-, high-, and very high-risk groups for posttransplant skin cancer. To assess skin cancer risk among SOT recipients and to evaluate the impact of a modified SUNTRAC-based surveillance program on screening rates, skin cancer incidence, and health care resource utilization. This was a retrospective cohort study of adult patients (≥18 years) who underwent SOT from January 1, 2016, to March 31, 2023. SOT recipients and nonrecipients were identified from the transplant registry of Kaiser Permanente Northern California (KPNC), an integrated health care delivery system providing care to more than 4.5 million members. SOT recipients were matched 1:20 on sex, race and ethnicity, and medical facility with nonrecipients. The study period was divided into preimplementation of the modified SUNTRAC (ie, KP-SUNTRAC) program (2016-2021) and postimplementation (2022-2024) periods. Included participants were followed up through March 31, 2024. Data were analyzed from July 2024 to June 2025. Implementation of KP-SUNTRAC risk-based skin cancer surveillance program. Among SOT recipients, the number of skin cancer screenings; skin cancer incident rates for basal cell carcinoma, cutaneous squamous cell carcinoma, cutaneous melanoma, or Merkel cell carcinoma; and health care resource utilization, measured by dermatology and nondermatology encounters and pathology specimen counts. The analysis included 2083 SOT recipients matched with 26 199 nonrecipients and found a 7.8-fold increased risk of developing skin cancer posttransplant among the SOT recipients compared with nonrecipients (hazard ratio [HR], 7.78; 95% CI, 5.97-10.10). After KP-SUNTRAC implementation, the risk of first detected skin cancer was significantly higher in the postimplementation group (HR, 2.57; 95% CI, 1.76-3.73). During the postimplementation period, screening rates significantly improved among the high-risk (HR, 1.98; 95% CI, 1.39-2.82) and very high-risk (HR, 2.17; 95% CI, 1.21-3.86) groups compared with preimplementation. Health care utilization did not increase after KP-SUNTRAC implementation. This cohort study found that KP-SUNTRAC was associated with improved skin cancer screening rates and detection among SOT recipients at higher risk of developing skin cancer, without increasing short-term health care utilization. This targeted surveillance approach supports timely diagnosis and has the potential to reduce morbidity and future health care costs.31:Tfc5, Importance Solid organ transplant (SOT) recipients are at increased risk for skin cancer due to long-term immunosuppression. However, this risk is heterogeneous across the SOT population. The Skin and Ultraviolet Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) incorporates established clinical risk factors to stratify SOT recipients into low-, medium-, high-, and very high−risk groups for posttransplant skin cancer. Objective To assess skin cancer risk among SOT recipients and to evaluate the impact of a modified SUNTRAC-based surveillance program on screening rates, skin cancer incidence, and health care resource utilization. Design, Settings, and Participants This was a retrospective cohort study of adult patients (≥18 years) who underwent SOT from January 1, 2016, to March 31, 2023. SOT recipients and nonrecipients were identified from the transplant registry of Kaiser Permanente Northern California (KPNC), an integrated health care delivery system providing care to more than 4.5 million members. SOT recipients were matched 1:20 on sex, race and ethnicity, and medical facility with nonrecipients. The study period was divided into preimplementation of the modified SUNTRAC (ie, KP-SUNTRAC) program (2016-2021) and postimplementation (2022-2024) periods. Included participants were followed up through March 31, 2024. Data were analyzed from July 2024 to June 2025. Exposure Implementation of KP-SUNTRAC risk-based skin cancer surveillance program. Main Outcomes and Measures Among SOT recipients, the number of skin cancer screenings; skin cancer incident rates for basal cell carcinoma, cutaneous squamous cell carcinoma, cutaneous melanoma, or Merkel cell carcinoma; and health care resource utilization, measured by dermatology and nondermatology encounters and pathology specimen counts. Results The analysis included 2083 SOT recipients matched with 26 199 nonrecipients and found a 7.8-fold increased risk of developing skin cancer posttransplant among the SOT recipients compared with nonrecipients (hazard ratio [HR], 7.78; 95% CI, 5.97-10.10). After KP-SUNTRAC implementation, the risk of first detected skin cancer was significantly higher in the postimplementation group (HR, 2.57; 95% CI, 1.76-3.73). During the postimplementation period, screening rates significantly improved among the high-risk (HR, 1.98; 95% CI, 1.39-2.82) and very high−risk (HR, 2.17; 95% CI, 1.21-3.86) groups compared with preimplementation. Health care utilization did not increase after KP-SUNTRAC implementation. Conclusions and Relevance This cohort study found that KP-SUNTRAC was associated with improved skin cancer screening rates and detection among SOT recipients at higher risk of developing skin cancer, without increasing short-term health care utilization. This targeted surveillance approach supports timely diagnosis and has the potential to reduce morbidity and future health care costs. 25:[[["$","script","0",{"type":"application/ld+json","dangerouslySetInnerHTML":{"__html":"{\"@context\":\"https://schema.org\",\"@type\":\"CollectionPage\",\"name\":\"Screening Program: modality Research & Clinical Takeaways\",\"description\":\"Explore peer-reviewed papers on Screening Program (modality). Clinician-written summaries and actionable practice insights. Updated daily.\",\"url\":\"https://www.reachrx.ai/hub/tag/modality/Screening%20Program\",\"breadcrumb\":{\"@type\":\"BreadcrumbList\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https://www.reachrx.ai\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research Hub\",\"item\":\"https://www.reachrx.ai/hub\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Modalities\",\"item\":\"https://www.reachrx.ai/hub/tag/modality\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Screening Program\",\"item\":\"https://www.reachrx.ai/hub/tag/modality/Screening%20Program\"}]}}"}}]],["$","$L2f",null,{"title":"Screening Program: Research & Clinical Takeaways","description":"Review evidence by treatment modality: Screening Program — concise summaries and practical next steps.","papers":[{"doi":"10.1001/jamadermatol.2025.3890","pmid":"41091513","title":"Skin Cancer Surveillance Program for Solid Organ Transplant Recipients","journal_title":"JAMA Dermatology","journal_issn":"2168-6068","published_at":"2025-10-15T00:00:00.000Z","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12529332/","source_score":36,"is_retracted":false,"is_open_access":true,"raw_metadata":{"ooir":{"day":"2025-12-19","doi":"10.1001/jamadermatol.2025.3890","days":"30","issn":"2168-6068","rank":"8","field":"Clinical Medicine","score":"36","category":"Dermatology","categories":["Dermatology"],"_categories":["Dermatology"]},"pubmed":{"doi":"10.1001/jamadermatol.2025.3890","title":"Skin Cancer Surveillance Program for Solid Organ Transplant Recipients.","journal":"JAMA dermatology","methods":"","results":"The analysis included 2083 SOT recipients matched with 26 199 nonrecipients and found a 7.8-fold increased risk of developing skin cancer posttransplant among the SOT recipients compared with nonrecipients (hazard ratio [HR], 7.78; 95% CI, 5.97-10.10). After KP-SUNTRAC implementation, the risk of first detected skin cancer was significantly higher in the postimplementation group (HR, 2.57; 95% CI, 1.76-3.73). During the postimplementation period, screening rates significantly improved among the high-risk (HR, 1.98; 95% CI, 1.39-2.82) and very high-risk (HR, 2.17; 95% CI, 1.21-3.86) groups compared with preimplementation. Health care utilization did not increase after KP-SUNTRAC implementation.","abstract":"$30","keywords":[],"pubmed_id":"41091513","conclusions":"","publication_date":"2025-10-15T00:00:00"},"crossref":{"DOI":"10.1001/jamadermatol.2025.3890","URL":"https://doi.org/10.1001/jamadermatol.2025.3890","ISSN":["2168-6068"],"link":[{"URL":"https://jamanetwork.com/journals/jamadermatology/articlepdf/2840146/jamadermatology_lee_2025_oi_250050_1765313913.97069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"page":"1238","type":"journal-article","issue":"12","score":1,"title":["Skin Cancer Surveillance Program for Solid Organ Transplant Recipients"],"author":[{"given":"David S.","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Dermatology, Kaiser Permanente Northern California, Pleasanton"}]},{"given":"Lusine","family":"Gigoyan","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Pleasanton"}]},{"given":"Ryan E.","family":"Sells","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kaiser Permanente Northern California, Pleasanton"}]},{"given":"Joshua R.","family":"Nugent","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Pleasanton"}]},{"given":"Nelson B.","family":"Goes","sequence":"additional","affiliation":[{"name":"Kidney Transplant Clinics, Department of Nephrology, Kaiser Permanente Northern California, Pleasanton"}]},{"given":"Hugh R.","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Kaiser Permanente Northern California, Santa Clara"},{"name":"Stanford University School of Medicine, Stanford, California"}]},{"given":"Erna O.","family":"Nishime","sequence":"additional","affiliation":[{"name":"Center for Advanced Heart Failure Therapies, Cardiac Transplant Department, Kaiser Permanente Northern California, Santa Clara"}]},{"given":"Gurpreet K.","family":"Rihal","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Kaiser Permanente Northern California, San Jose"}]},{"given":"David L.","family":"Conant","sequence":"additional","affiliation":[{"name":"Department of Adult and Family Medicine, Kaiser Permanente Northern California, San Rafael"}]},{"given":"Ngoc","family":"Pham","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kaiser Permanente Northern California, Santa Clara"}]},{"given":"Marilyn L.","family":"Kwan","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Pleasanton"}]}],"issued":{"date-parts":[[2025,12,1]]},"member":"10","prefix":"10.1001","source":"Crossref","volume":"161","created":{"date-time":"2025-10-15T15:01:50Z","timestamp":1760540510000,"date-parts":[[2025,10,15]]},"indexed":{"date-time":"2025-12-17T18:20:11Z","timestamp":1765995611851,"date-parts":[[2025,12,17]]},"subject":[],"abstract":"$31","language":"en","relation":{},"resource":{"primary":{"URL":"https://jamanetwork.com/journals/jamadermatology/fullarticle/2840146"}},"subtitle":[],"deposited":{"date-time":"2025-12-17T16:00:30Z","timestamp":1765987230000,"date-parts":[[2025,12,17]]},"issn-type":[{"type":"print","value":"2168-6068"}],"published":{"date-parts":[[2025,12,1]]},"publisher":"American Medical Association (AMA)","reference":[{"DOI":"10.1067/mjd.2002.125579","key":"doi250050r1","year":"2002","issue":"1","author":"Berg","volume":"47","first-page":"1","unstructured":null,"article-title":"Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/S0190-9622(99)70185-4","key":"doi250050r2","year":"1999","issue":"2 Pt 1","author":"Jensen","volume":"40","first-page":"177","unstructured":null,"article-title":"Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/bjd.18094","key":"doi250050r3","year":"2019","issue":"5","author":"Menzies","volume":"181","first-page":"983","unstructured":null,"article-title":"Declining incidence of keratinocyte carcinoma in organ transplant recipients.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2022.0036","key":"doi250050r4","year":"2022","issue":"4","author":"Sargen","volume":"158","first-page":"414","unstructured":null,"article-title":"Spectrum of nonkeratinocyte skin cancer risk among solid organ transplant recipients in the US.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2016.02.1155","key":"doi250050r5","year":"2016","issue":"1","author":"Garrett","volume":"75","first-page":"106","unstructured":null,"article-title":"Trends of skin cancer mortality after transplantation in the United States: 1987 to 2013.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2023.08.077","key":"doi250050r6","year":"2024","issue":"1","author":"O’Connell","volume":"90","first-page":"150","unstructured":null,"article-title":"Cost of skin cancer-related dermatological care is higher in transplant recipients compared with nonimmunosuppressed patients.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1007/s00403-024-03680-z","key":"doi250050r7","year":"2025","issue":"1","author":"Aristizabal","volume":"317","first-page":"295","unstructured":null,"article-title":"Comparative analysis of quality of life in solid organ transplant recipients: the influence of skin cancer.","journal-title":"Arch Dermatol Res","doi-asserted-by":"publisher"},{"DOI":"10.1111/ajt.14966","key":"doi250050r8","year":"2019","issue":"2","author":"Chan","volume":"19","first-page":"522","unstructured":null,"article-title":"Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: population-based cohort study.","journal-title":"Am J Transplant","doi-asserted-by":"publisher"},{"DOI":"10.1684/ejd.2020.3845","key":"doi250050r9","year":"2020","issue":"4","author":"Cordaro","volume":"30","first-page":"372","unstructured":null,"article-title":"Skin cancer screening in organ transplant centres in the United Kingdom: a national survey.","journal-title":"Eur J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/ajt.15224","key":"doi250050r10","year":"2019","issue":"6","author":"Lam","volume":"19","first-page":"1792","unstructured":null,"article-title":"Skin cancer screening after solid organ transplantation: Survey of practices in Canada.","journal-title":"Am J Transplant","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2022.11.052","key":"doi250050r11","year":"2023","issue":"5","author":"Shope","volume":"88","first-page":"1159","unstructured":null,"article-title":"Referrals to dermatology following solid organ transplant.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/ajt.13978","key":"doi250050r12","year":"2017","issue":"1","author":"Acuna","volume":"17","first-page":"103","unstructured":null,"article-title":"Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines.","journal-title":"Am J Transplant","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2021.05.029","key":"doi250050r13","year":"2022","issue":"6","author":"Fernandez","volume":"86","first-page":"1369","unstructured":null,"article-title":"Examining low rates of dermatology visits in solid organ transplant recipients.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/tri.13493","key":"doi250050r14","year":"2019","issue":"12","author":"Jambusaria-Pahlajani","volume":"32","first-page":"1259","unstructured":null,"article-title":"Predicting skin cancer in organ transplant recipients: development of the SUNTRAC screening tool using data from a multicenter cohort study.","journal-title":"Transpl Int","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2016.4920","key":"doi250050r15","year":"2017","issue":"3","author":"Garrett","volume":"153","first-page":"296","unstructured":null,"article-title":"Incidence of and risk factors for skin cancer in organ transplant recipients in the United States.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.7812/TPP/22.172","key":"doi250050r16","year":"2023","issue":"2","author":"Davis","volume":"27","first-page":"87","unstructured":null,"article-title":"Comparing Kaiser Permanente members to the general population: implications for generalizability of research.","journal-title":"Perm J","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2019.01.067","key":"doi250050r17","year":"2019","issue":"5","author":"Marwaha","volume":"81","first-page":"1099","unstructured":null,"article-title":"Comparative effectiveness study of face-to-face and teledermatology workflows for diagnosing skin cancer.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1007/s11524-006-9094-x","key":"doi250050r18","year":"2006","issue":"6","author":"Messer","volume":"83","first-page":"1041","unstructured":null,"article-title":"The development of a standardized neighborhood deprivation index.","journal-title":"J Urban Health","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2021.07.065","key":"doi250050r19","year":"2022","issue":"3","author":"Dusendang","volume":"86","first-page":"598","unstructured":null,"article-title":"Cohort and nested case-control study of cutaneous squamous cell carcinoma in solid organ transplant recipients, by medication.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/bjd.19550","key":"doi250050r20","year":"2021","issue":"3","author":"Jiyad","volume":"184","first-page":"545","unstructured":null,"article-title":"A call to standardize the BCC:SCC ratio.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1097/00007890-199003000-00006","key":"doi250050r21","year":"1990","issue":"3","author":"Hartevelt","volume":"49","first-page":"506","unstructured":null,"article-title":"Incidence of skin cancer after renal transplantation in The Netherlands.","journal-title":"Transplantation","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2017.2984","key":"doi250050r22","year":"2017","issue":"12","author":"Rizvi","volume":"153","first-page":"1270","unstructured":null,"article-title":"Long-term change in the risk of skin cancer after organ transplantation: a population-based nationwide cohort study.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2022.4820","key":"doi250050r23","year":"2023","issue":"1","author":"Gómez-Tomás","volume":"159","first-page":"29","unstructured":null,"article-title":"External Validation of the Skin and UV Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) in a large european solid organ transplant recipient cohort.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1093/ced/llad298","key":"doi250050r24","year":"2023","issue":"1","author":"Yoo","volume":"49","first-page":"68","unstructured":null,"article-title":"Assessing the Skin and UV Neoplasia Transplant Risk Assessment Calculator in an Irish cohort of thoracic organ transplant recipients.","journal-title":"Clin Exp Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2021.4148","key":"doi250050r25","year":"2021","issue":"12","author":"Wehner","volume":"157","first-page":"1447","unstructured":null,"article-title":"Risks of multiple skin cancers in organ transplant recipients: a cohort study in 2 administrative data sets.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1097/DSS.0000000000003844","key":"doi250050r26","year":"2023","issue":"8","author":"Plampton","volume":"49","first-page":"803","unstructured":null,"article-title":"Skin cancer as a chronic disease: a retrospective cohort study validating impact on healthcare utilization and quality of life.","journal-title":"Dermatol Surg","doi-asserted-by":"publisher"},{"DOI":"10.6004/jnccn.2010.0066","key":"doi250050r27","year":"2010","issue":"8","author":"Mudigonda","volume":"8","first-page":"888","unstructured":null,"article-title":"The economic impact of non-melanoma skin cancer: a review.","journal-title":"J Natl Compr Canc Netw","doi-asserted-by":"publisher"},{"DOI":"10.1007/s10552-022-01644-0","key":"doi250050r28","year":"2023","issue":"3","author":"Kao","volume":"34","first-page":"205","unstructured":null,"article-title":"Economic burden of skin cancer treatment in the USA: an analysis of the Medical Expenditure Panel Survey Data, 2012-2018.","journal-title":"Cancer Causes Control","doi-asserted-by":"publisher"},{"DOI":"10.1111/tid.13428","key":"doi250050r29","year":"2021","issue":"1","author":"Bennett","volume":"23","first-page":null,"unstructured":null,"article-title":"Impact of SARS-CoV-2 outbreak on heart and lung transplant: a patient-perspective survey.","journal-title":"Transpl Infect Dis","doi-asserted-by":"publisher"}],"short-title":[],"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"content-domain":{"domain":[],"crossmark-restriction":false},"original-title":[],"container-title":["JAMA Dermatology"],"published-print":{"date-parts":[[2025,12,1]]},"reference-count":29,"published-online":null,"references-count":29,"short-container-title":["JAMA Dermatol"],"is-referenced-by-count":1},"unpaywall":{"doi":"10.1001/jamadermatol.2025.3890","is_oa":true,"title":"Skin Cancer Surveillance Program for Solid Organ Transplant Recipients","updated":"2025-12-21T03:41:08+00:00","published_date":"2025-10-15","best_oa_location":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12529332/","pmh_id":"oai:pubmedcentral.nih.gov:12529332","url_for_pdf":null,"url_for_landing_page":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12529332/"}}},"created_at":"2025-10-20T07:02:36.724Z","updated_at":"2026-01-18T22:40:12.285Z","tags":[{"paper_doi":"10.1001/jamadermatol.2025.3890","tag_type":"age_group","value":"adult","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.3890","tag_type":"category","value":"Dermatology","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.3890","tag_type":"condition","value":"Skin Cancer","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.3890","tag_type":"impact_flag","value":"limited_evidence","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.3890","tag_type":"level_of_evidence","value":"3","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.3890","tag_type":"modality","value":"Screening Program","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.3890","tag_type":"sample_size","value":"n=28,282","value_numeric":28282},{"paper_doi":"10.1001/jamadermatol.2025.3890","tag_type":"study_design","value":"Retrospective Cohort Study","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.3890","tag_type":"warning","value":"Causal attribution is uncertain due to the pre/post observational design without randomization.","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.3890","tag_type":"warning","value":"Generalizability may be limited to an integrated health system (KPNC).","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.3890","tag_type":"warning","value":"Outcomes are reported as hazard ratios; absolute incidence numbers by group were not provided.","value_numeric":null}],"summaries":{"what_studied":"A retrospective cohort at an integrated health system evaluated a modified SUNTRAC risk‑based surveillance program (KP‑SUNTRAC) for adult solid organ transplant recipients, comparing preimplementation (2016–2021) vs postimplementation (2022–2024) with follow‑up through March 31, 2024; SOT recipients (n=2,083) were also matched 1:20 to nonrecipients (n=26,199).","key_result":"SOT recipients had a 7.8-fold higher skin cancer risk than matched nonrecipients (HR 7.78; 95% CI, 5.97–10.10). After KP‑SUNTRAC, first detected skin cancer increased (HR 2.57; 95% CI, 1.76–3.73) and screening rates improved in high‑risk (HR 1.98; 95% CI, 1.39–2.82) and very high‑risk groups (HR 2.17; 95% CI, 1.21–3.86), without increased health care utilization.","limitations":"Retrospective pre/post design within a single integrated health system (KPNC) limits causal inference and generalizability. Absolute incidence rates or event counts by group were not reported.","practice_takeaway":"In an integrated setting, risk‑stratified surveillance for SOT recipients improved dermatologic screening and cancer detection in higher‑risk groups without raising short‑term utilization. Programs caring for transplant patients can consider structured risk tools like SUNTRAC to prioritize screening intensity."}}],"initialOffset":1,"fetchConfig":{"kind":"tags","tags":[{"tag_type":"modality","value":"Screening Program"}]},"breadcrumbItems":[{"name":"Home","href":"/"},{"name":"Research Hub","href":"/hub"},{"name":"Modalities","href":"/hub/tag/modality"},{"name":"Screening Program"}],"hrefConfig":{"basePath":"/hub/papers","webViewQueryParams":{"hub_ctx":"tag","hub_tag_type":"modality","hub_tag_value":"Screening Program"}}}]]

Papers